abstract |
The present application discloses 2-acetamido-3-carbomethoxy-5-(6,7-dihydro- 6-oxo-4-arylamido pyrrolo[2,3-d]pyrimidine –5-)methylene-1H-pyrrole derivatives of general formula (I),processes for their preparation, the pharmaceutical compositions containing them and their uses as therapeutic agents especially as protein kinase inhibitors. The definitions of substituents in formula (I) are the same as description. |